Published in Arthritis Rheum on October 15, 2008
Qigong vs. Aerobic Exercise in the Treatment of Childhood Chronic Musculoskeletal Pain | NCT00312234
Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther (2010) 1.67
Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int (2012) 1.10
Complementary and alternative exercise for fibromyalgia: a meta-analysis. J Pain Res (2013) 1.07
[Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. Schmerz (2012) 1.03
[Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. Schmerz (2012) 1.00
Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics (2014) 1.00
Physical activity monitoring in adolescents with juvenile fibromyalgia: findings from a clinical trial of cognitive-behavioral therapy. Arthritis Care Res (Hoboken) (2013) 0.90
A systematic review and meta-analysis of qigong for the fibromyalgia syndrome. Evid Based Complement Alternat Med (2013) 0.87
Juvenile fibromyalgia: current status of research and future developments. Nat Rev Rheumatol (2013) 0.87
Bidirectional associations between pain and physical activity in adolescents. Clin J Pain (2014) 0.86
Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia. Clin J Pain (2013) 0.85
Qigong and fibromyalgia: randomized controlled trials and beyond. Evid Based Complement Alternat Med (2014) 0.84
Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial. Arthritis Res Ther (2013) 0.84
[Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline]. Schmerz (2012) 0.83
The role of benign joint hypermobility in the pain experience in Juvenile Fibromyalgia: an observational study. Pediatr Rheumatol Online J (2012) 0.82
Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol Online J (2015) 0.80
Extension trial of qigong for fibromyalgia: a quantitative and qualitative study. Evid Based Complement Alternat Med (2013) 0.79
Can behavioral treatments be enhanced by integrative neuromuscular training in the treatment of juvenile fibromyalgia? Pain Manag (2012) 0.79
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J (2016) 0.78
Nonpharmacological treatment of pain in rheumatic diseases and other musculoskeletal pain conditions. Curr Rheumatol Rep (2013) 0.78
A Qualitative Examination of a New Combined Cognitive-Behavioral and Neuromuscular Training Intervention for Juvenile Fibromyalgia. Clin J Pain (2016) 0.77
Preliminary outcomes of a cross-site cognitive-behavioral and neuromuscular integrative training intervention for juvenile fibromyalgia. Arthritis Care Res (Hoboken) (2016) 0.77
A survey of conventional and complementary therapies used by youth with juvenile-onset fibromyalgia. Pain Manag Nurs (2012) 0.76
Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials. Sci Rep (2015) 0.76
Process evaluations in neurological rehabilitation: a mixed-evidence systematic review and recommendations for future research. BMJ Open (2016) 0.75
Physical activity levels in the treatment of juvenile fibromyalgia. Nat Rev Rheumatol (2012) 0.75
Fibromyalgia: Treating Pain in the Juvenile Patient. Paediatr Drugs (2017) 0.75
Qigong and Fibromyalgia circa 2017. Medicines (Basel) (2017) 0.75
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res (2004) 5.68
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain (2008) 4.59
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med (2012) 4.15
The use of oxygen in acute exacerbations of chronic obstructive pulmonary disease: a prospective audit of pre-hospital and hospital emergency management. Clin Med (2002) 3.93
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum (2013) 3.55
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med (2012) 3.14
A systematic review of the effect of waiting for treatment for chronic pain. Pain (2007) 2.52
Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum (2005) 2.48
Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum (2007) 2.41
Asking the experts: exploring the self-management needs of adolescents with arthritis. Arthritis Rheum (2008) 2.40
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum (2004) 2.31
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2009) 2.31
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) (2012) 2.21
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) (2003) 2.18
Access to biologic therapies in Canada for children with juvenile idiopathic arthritis. J Rheumatol (2012) 1.97
Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol (2002) 1.97
Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol (2010) 1.93
Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol (2003) 1.90
An integrated undergraduate pain curriculum, based on IASP curricula, for six health science faculties. Pain (2004) 1.87
Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum (2008) 1.81
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum (2005) 1.75
Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol (2010) 1.70
Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol (2012) 1.70
Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum (2006) 1.69
Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr (2007) 1.66
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol (2010) 1.66
Epidemiology and management of painful procedures in children in Canadian hospitals. CMAJ (2011) 1.66
Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) (2010) 1.65
Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they? J Rheumatol (2009) 1.63
Primary central nervous system vasculitis in children. Arthritis Rheum (2006) 1.62
IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis (2013) 1.59
Methods to elicit beliefs for Bayesian priors: a systematic review. J Clin Epidemiol (2009) 1.59
An interfaculty pain curriculum: lessons learned from six years experience. Pain (2008) 1.58
Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors. J Rheumatol (2010) 1.58
Takayasu arteritis in children and adolescents. Rheumatology (Oxford) (2010) 1.58
Reliability and validity of the Child Pain Anxiety Symptoms Scale (CPASS) in a clinical sample of children and adolescents with acute postsurgical pain. Pain (2011) 1.56
Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma. J Rheumatol (2009) 1.54
Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken) (2013) 1.53
Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum (2002) 1.52
Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum (2007) 1.52
Clinical and cost implications of target joints in Canadian boys with severe hemophilia A. J Pediatr (2004) 1.50
Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum (2007) 1.50
An internet-based self-management program with telephone support for adolescents with arthritis: a pilot randomized controlled trial. J Rheumatol (2010) 1.47
The Quality of My Life questionnaire: the minimal clinically important difference for pediatric rheumatology patients. J Rheumatol (2006) 1.47
A new toolkit for conducting clinical trials in rare disorders. J Popul Ther Clin Pharmacol (2014) 1.47
Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol (2011) 1.46
Development of a challenge assessment tool for high-functioning children with an acquired brain injury. Pediatr Phys Ther (2010) 1.46
e-Ouch: usability testing of an electronic chronic pain diary for adolescents with arthritis. Clin J Pain (2006) 1.46
The application of motor learning strategies within functionally based interventions for children with neuromotor conditions. Pediatr Phys Ther (2009) 1.45
Use and accuracy of US guidance for image-guided injections of the temporomandibular joints in children with arthritis. Pediatr Radiol (2010) 1.45
Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis. J Rheumatol (2002) 1.44
The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. JPEN J Parenter Enteral Nutr (2011) 1.44
Sinus bradycardia after intravenous pulse methylprednisolone. Pediatrics (2007) 1.44
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum (2003) 1.42
The motor learning strategy instrument: interrater reliability within usual and virtual reality physical therapy interventions. Pediatr Phys Ther (2013) 1.40
In a child presenting with features consistent with a diagnosis of juvenile idiopathic arthritis, what clinical features or laboratory findings (at presentation) predict a diagnosis of acute lymphoblastic leukaemia? J Paediatr Child Health (2010) 1.39
Childhood primary angiitis of the central nervous system: identifying disease trajectories and early risk factors for persistently higher disease activity. Arthritis Rheum (2012) 1.39
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
Usability testing of an online self-management program for adolescents with juvenile idiopathic arthritis. J Med Internet Res (2010) 1.36
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2012) 1.33
Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) (2010) 1.32
Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum (2011) 1.32
Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag (2014) 1.31
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum (2009) 1.30
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A (2011) 1.30
Construct validity of a multidimensional electronic pain diary for adolescents with arthritis. Pain (2007) 1.25
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken) (2012) 1.25
Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics (2005) 1.24
Juvenile idiopathic arthritis. Pediatr Clin North Am (2012) 1.24
Use of complementary and alternative medicine by pediatric rheumatology patients. Arthritis Rheum (2003) 1.22
Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Arthritis Rheum (2011) 1.22
Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med (2005) 1.22
Systematic review of family functioning in families of children and adolescents with chronic pain. J Pain (2010) 1.20
Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol (2005) 1.19
Commentary: the Journal of Pediatric Psychology should adopt the CONSORT statement as a way of improving the evidence base in pediatric psychology. J Pediatr Psychol (2003) 1.18
Validation of the numerical rating scale for pain intensity and unpleasantness in pediatric acute postoperative pain: sensitivity to change over time. J Pain (2012) 1.18
Towards a consensus-based classification of childhood arterial ischemic stroke. Stroke (2011) 1.17
The risky business of studying prognosis. J Rheumatol (2012) 1.17